Ni Jie, Cozzi Paul, Hung Tzong-Tyng, Hao Jingli, Graham Peter, Li Yong
Cancer Care Centre, St George Hospital, Kogarah, NSW 2217, Australia; St George and Sutherland Clinical School, the University of New South Wales (UNSW), Kensington, NSW 2052, Australia.
St George and Sutherland Clinical School, the University of New South Wales (UNSW), Kensington, NSW 2052, Australia; Department of Surgery, St George Hospital, Kogarah, NSW 2217, Australia.
Transl Oncol. 2016 Feb;9(1):41-45. doi: 10.1016/j.tranon.2015.11.011.
Prostate cancer (CaP) is the most commonly diagnosed and the second leading cause of death from cancer in males in USA. Prostate orthotopic mouse model has been widely used to study human CaP in preclinical settings. Measurement of changes in tumor size obtained from noninvasive diagnostic images is a standard method for monitoring responses to anticancer modalities. This article reports for the first time the usage of a three-dimensional (3D) ultrasound system equipped with photoacoustic (PA) imaging in monitoring longitudinal prostate tumor growth in a PC-3 orthotopic NODSCID mouse model (n = 8). Two-dimensional and 3D modes of ultrasound show great ability in accurately depicting the size and shape of prostate tumors. PA function on two-dimensional and 3D images showed average oxygen saturation and average hemoglobin concentration of the tumor. Results showed a good fit in representative exponential tumor growth curves (n = 3; r(2) = 0.948, 0.955, and 0.953, respectively) and a good correlation of tumor volume measurements performed in vivo with autopsy (n = 8, r = 0.95, P < .001). The application of 3D ultrasound imaging proved to be a useful imaging modality in monitoring tumor growth in an orthotopic mouse model, with advantages such as high contrast, uncomplicated protocols, economical equipment, and nonharmfulness to animals. PA mode also enabled display of blood oxygenation surrounding the tumor and tumor vasculature and angiogenesis, making 3D ultrasound imaging an ideal tool for preclinical cancer research.
前列腺癌(CaP)是美国男性中最常被诊断出的癌症,也是癌症死亡的第二大主要原因。前列腺原位小鼠模型已被广泛用于临床前环境中对人类CaP的研究。从无创诊断图像中测量肿瘤大小的变化是监测抗癌治疗反应的标准方法。本文首次报道了在PC-3原位NODSCID小鼠模型(n = 8)中使用配备光声(PA)成像的三维(3D)超声系统监测前列腺肿瘤的纵向生长。二维和三维超声模式在准确描绘前列腺肿瘤的大小和形状方面显示出强大的能力。二维和三维图像上的PA功能显示了肿瘤的平均氧饱和度和平均血红蛋白浓度。结果显示在代表性的指数肿瘤生长曲线中拟合良好(n = 3;r²分别为0.948、0.955和0.953),并且体内进行的肿瘤体积测量与尸检结果具有良好的相关性(n = 8,r = 0.95,P <.001)。3D超声成像的应用被证明是监测原位小鼠模型中肿瘤生长的一种有用的成像方式,具有高对比度、方案简单、设备经济以及对动物无害等优点。PA模式还能够显示肿瘤周围的血液氧合以及肿瘤血管和血管生成,使3D超声成像成为临床前癌症研究的理想工具。